بوابة الفجر
بوابة الفجر
Ready to play
Ready to play
A recent study has shown that higher cumulative doses of Clomiphene citrate, a drug used to treat infertility and stimulate ovulation, increase the risks of pregnancy loss and multiple births, without improving the chances of live birth. The study found that the miscarriage rate rises with increasing dosage, reaching 14.4% at doses between 750 and 999 mg, and that the likelihood of multiple pregnancy increases with doses of 750 mg or more. Despite the increased risks, the study did not demonstrate a clear benefit of increasing the dose to enhance the chances of a live birth, and there were indications of potential risks such as stillbirth. This underscores the importance of individual dose assessment and the need to limit unnecessary use.
Notice: This Is an AI-Generated Summary
Comments (0)